ViaLongeVita

From the Czech desk of MedScopeGlobal. Shared with attribution — the local desk added context for this edition.

A phase 1 trial of CD123-directed chimeric antigen receptor T-cell therapy in adults with relapsed/refractory acute myeloid leukemia or blastic plasmacytoid dendritic cell neoplasmVIP

J Hematol Oncol — Budde LE, Del Real MM, Song J

From the Czech desk of MedScopeGlobal

7 de agosto de 2026

Salvar

Este conteúdo não é diagnóstico médico nem recomendação de tratamento. Consulte sempre o seu médico ou o SUS.

Illustration for "A phase 1 trial of CD123-directed chimeric antigen receptor T-cell therapy in adults with relapsed/refractory acute myeloid leukemia or blastic plasmacytoid dendritic cell neoplasm" — healthy lifestyle, diverse group of adults

Did this article help? Leave a tip — you keep the next reader reading

J Hematol Oncol — Budde LE, Del Real MM, Song J

Exkluzivně pro předplatitele

Pokračujte ve čtení s MedScope Premium

VIP články obsahují klinické dopady, klíčové body a ověřené zdroje — navržené pro studenty a lékaře.

14 dní zkušební verze zdarma — vyzkoušejte bez rizika

Vybrat plán

Již máte účet? Přihlásit se · Srovnání tarifů

Support the author (MedScopeGlobal Editorial) · Tip

Optional micro-contribution — like a tip. When you give, the next reader still gets a clear health text.

A tip is not a VIP subscription and does not unlock paid content — it is optional support for the desk.

Contribution

Donate

A micro-donation keeps clear health writing open for the next person.

Conteúdo recomendado

Artigos

Prepared by the MedScopeGlobal.com editorial team — educational health content for the public. Always consult a physician for personal medical decisions.